Randomized phase II trial of first-line treatment with tailored irinotecan and S-1 therapy versus S-1 monotherapy for advanced or recurrent gastric carcinoma (JFMC31-0301)
暂无分享,去创建一个
Y. Tajima | J. Sakamoto | S. Tatebe | S. Saji | M. Kitajima | Y. Sakata | Masahiro Takahashi | Y. Komatsu | Y. Kimura | Yutaka Takahashi | S. Tamura | H. Oda | T. Wakasugi | J. Sakurai